A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.
Daily News Roundup
A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.
A genomic analysis reveals a crucial detail in drug-resistant strains of the malaria parasite that are on the move in Southeast Asia.
Extra inches may mean a higher chance of getting ovarian cancer.
A new study shows that transcription of genes in trypanosome parasites is regulated by genome organization.
Researchers put the predictive power of whole genome sequencing to the test.
Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.
The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.
A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.
Mice “avatars” grafted with patient tumor tissue help identify effective drug regimens.
Are donors of biological material privy to research results that stem from their donation?